Thus, decreased renal function needs to be considered in the interpretation of HE4 levels with greater importance in endometrial cancer patients, where the elevation of serum HE4 is often subtle compared to ovarian cancer patients. This evidence concerns the gene WFDC2 and endometrial cancer.